Home CannaBusiness

CannaBusiness

22nd Century Partners with The University of Virginia to Utilize Industrial Hemp to Clean Up and Reclaim Polluted Lands

22nd Century’s proprietary industrial hemp could revolutionize land reclamation initiatives across the United States CLARENCE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company focused on tobacco harm reduction and cannabis research, announced today that, together with The University of Virginia (UVA), it has launched a project aimed at utilizing novel varieti June 20, 2017

Global Substance Abuse Treatment Market – Size, Projections, Drivers, Trends, Vendors, and Analysis Through 2021 by Technavio

LONDON–(BUSINESS WIRE)–According to the latest market study released by Technavio, the global substance abuse treatment market is projected to grow to more than USD 18,122 million by 2021, at a CAGR exceeding 5% over the forecast period. This research report titled ‘Global Substance Abuse Treatment Market 2017-2021’ provides an in-depth analysis of the mark June 19, 2017

22nd Century Meets with FDA on Modified Risk Tobacco Product Application for World’s Lowest Nicotine Tobacco Cigarettes

CLARENCE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today that the Company and its wholly-owned subsidiary, Goodrich Tobacco Company, held yesterday a very encouraging and productive meeting with the Office of Science of the Center for Tobacco Products (CTP) of the June 16, 2017

New International Survey Shows Overwhelming Support for Very Low Nicotine Cigarettes

74% of adults in the United States, Japan, Australia, Canada, and the United Kingdom believe “government should mandate that all cigarettes have very low, non-addictive levels of nicotine.” CLARENCE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is focused on tobacco harm reduction and cannabis research, announced today that the Co June 15, 2017

Tilray Announces Support for Clinical Trial Examining Cannabis and Chronic Lung Disease

Tilray partners with the Research Institute of the McGill University Health Centre to study the efficacy of medical cannabis in patients with chronic obstructive pulmonary disease (COPD) NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, a global leader in medical cannabis research and production, today announced a partnership with the Research Institute of the McGill University Health Centre (RI-MUH June 15, 2017

Tilray annonce son soutien à un essai clinique examinant le cannabis et la maladie pulmonaire chronique

Tilray conclut un partenariat avec l’institut de recherche du Centre universitaire de santé McGill, afin d’étudier l’efficacité du cannabis thérapeutique chez les patients souffrant de maladie pulmonaire obstructive chronique (MPOC) NANAIMO, Colombie-Britannique–(BUSINESS WIRE)–Tilray, leader mondial en recherche et en production de cannabis thérapeutique, a annoncé aujourd’hui un partenariat avec l’institut de recherche du Centre universitai June 15, 2017

908 Devices Introduces Next-Generation HPMS Device for the First Responder Community

MX908 brings enhanced detection and identification capabilities to modern-day response missions BOSTON–(BUSINESS WIRE)–908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced the release of MX908™, a second-generation handheld chemical detection and identification device powered by the Company’s patented and award-winning high-pressure mass spectrometry (HPMS™) technology. Designed for true trace-level dete June 14, 2017

CanniMed Therapeutics Inc. Reports Financial Results for Q2 2017

SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (TSX: CMED) (“CanniMed” or the “Company”) today released its financial results for the three and six months ended April 30, 2017. CanniMed’s strong sales momentum continued in the second quarter. Demand for oils has accounted for progressively more of the Company’s production, and CanniMed’s recently announced oils processing facili June 12, 2017

Caliva Partners With Thinfilm to Enable One-to-One Mobile Connections With Wellness Patients

Caliva Products Featuring Thinfilm Technology Deliver Unique Digital Experiences that Facilitate a More Informed and Transparent Buying Process OSLO, Norway–(BUSINESS WIRE)–Thin Film Electronics ASA (“Thinfilm”) (OSE: THIN), a global leader in NFC (near field communication) mobile marketing and smart product solutions, today announced a partnership with one of California’s leading cannabis companies, Caliva. Through June 9, 2017